TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 ID - Chen2016 ER - TY - JOUR AU - Lin, Y. AU - Totsuka, Y. AU - He, Y. PY - 2013 DA - 2013// TI - Epidemiology of esophageal cancer in Japan and China JO - J Epidemiol VL - 23 UR - https://doi.org/10.2188/jea.JE20120162 DO - 10.2188/jea.JE20120162 ID - Lin2013 ER - TY - JOUR AU - Pennathur, A. AU - Gibson, M. K. AU - Jobe, B. A. PY - 2013 DA - 2013// TI - Oesophageal carcinoma JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)60643-6 DO - 10.1016/S0140-6736(12)60643-6 ID - Pennathur2013 ER - TY - JOUR AU - Cooper, J. S. AU - Guo, M. D. AU - Herskovic, A. PY - 1999 DA - 1999// TI - Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.17.1623 DO - 10.1001/jama.281.17.1623 ID - Cooper1999 ER - TY - JOUR AU - Minsky, B. D. AU - Pajak, T. F. AU - Ginsberg, R. J. PY - 2002 DA - 2002// TI - INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.5.1167 DO - 10.1200/JCO.20.5.1167 ID - Minsky2002 ER - TY - JOUR AU - al-Sarraf, M. AU - Martz, K. AU - Herskovic, A. PY - 1997 DA - 1997// TI - Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study JO - J Clin Oncol VL - 15 UR - https://doi.org/10.1200/JCO.1997.15.1.277 DO - 10.1200/JCO.1997.15.1.277 ID - al-Sarraf1997 ER - TY - JOUR AU - Chen, Y. AU - Ye, J. AU - Zhu, Z. PY - 2019 DA - 2019// TI - Comparing paclitaxel plus fluorouracil versus Cisplatin plus fluorouracil in Chemoradiotherapy for locally advanced esophageal squamous cell Cancer: a randomized, multicenter, phase III clinical trial JO - J Clin Oncol VL - 37 UR - https://doi.org/10.1200/JCO.18.02122 DO - 10.1200/JCO.18.02122 ID - Chen2019 ER - TY - JOUR AU - Hagen, P. AU - Hulshof, M. C. AU - Lanschot, J. J. PY - 2012 DA - 2012// TI - Preoperative chemoradiotherapy for esophageal or junctional cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1112088 DO - 10.1056/NEJMoa1112088 ID - Hagen2012 ER - TY - JOUR AU - Wang, H. AU - Ryu, J. AU - Gandara, D. PY - 2007 DA - 2007// TI - A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer JO - J Thorac Oncol VL - 2 UR - https://doi.org/10.1097/JTO.0b013e31802bff75 DO - 10.1097/JTO.0b013e31802bff75 ID - Wang2007 ER - TY - JOUR AU - Honing, J. AU - Smit, J. K. AU - Muijs, C. T. PY - 2014 DA - 2014// TI - A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt589 DO - 10.1093/annonc/mdt589 ID - Honing2014 ER - TY - JOUR AU - Ruler, M. A. AU - Peters, F. P. AU - Slingerland, M. PY - 2017 DA - 2017// TI - Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer JO - Dis Esophagus VL - 30 UR - https://doi.org/10.1093/dote/dow033 DO - 10.1093/dote/dow033 ID - Ruler2017 ER - TY - STD TI - Ringel I, Horwitz SB. Sudies with RP 56976 (Taxotere): a semisynthertic analogue of Taxol. J Nalt Cancer Inst. 1991;83:288–91. ID - ref12 ER - TY - JOUR AU - Mason, K. A. AU - Hunter, N. R. AU - Milas, M. AU - Abbruzzese, J. L. AU - Milas, L. PY - 1997 DA - 1997// TI - Docetaxel enhances tumour radioresponse in vivo JO - Clin Cancer Res VL - 3 ID - Mason1997 ER - TY - JOUR AU - Wilson, G. D. AU - Bentzen, S. M. AU - Harari, P. M. PY - 2006 DA - 2006// TI - Biologic basis for combining drugs with radiation JO - Semin Radiat Oncol VL - 16 UR - https://doi.org/10.1016/j.semradonc.2005.08.001 DO - 10.1016/j.semradonc.2005.08.001 ID - Wilson2006 ER - TY - JOUR AU - LiQQ, L. M. Z. AU - Hu, Y. H. AU - Liu, H. AU - He, Z. Y. AU - Lin, H. X. PY - 2010 DA - 2010// TI - De nitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma JO - Dis Esophagus VL - 23 UR - https://doi.org/10.1111/j.1442-2050.2009.01003.x DO - 10.1111/j.1442-2050.2009.01003.x ID - LiQQ2010 ER - TY - JOUR AU - Laack, E. AU - Andritzky, B. AU - Dürk, H. PY - 2005 DA - 2005// TI - Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study JO - Onkologie VL - 28 ID - Laack2005 ER - TY - JOUR AU - Kim, J. Y. AU - Do, Y. R. AU - Park, K. U. PY - 2010 DA - 2010// TI - A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer JO - Cancer Chemother Pharmacol VL - 66 UR - https://doi.org/10.1007/s00280-009-1130-6 DO - 10.1007/s00280-009-1130-6 ID - Kim2010 ER - TY - JOUR AU - Ohtsu, A. AU - Boku, N. AU - Muro, K. PY - 1999 DA - 1999// TI - Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.9.2915 DO - 10.1200/JCO.1999.17.9.2915 ID - Ohtsu1999 ER - TY - JOUR AU - Makinoa, I. AU - Ninomiyaa, I. AU - Okamotoa, K. PY - 2011 DA - 2011// TI - A pilot study of Chemoradiotherapy with weekly Docetaxel for thoracic esophageal carcinoma with T4 and/or M1 lymph node metastasis JO - World J Oncol VL - 2 ID - Makinoa2011 ER - TY - JOUR AU - Lorenzen, S. AU - Duyster, J. AU - Lersch, C. PY - 2005 DA - 2005// TI - Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602645 DO - 10.1038/sj.bjc.6602645 ID - Lorenzen2005 ER - TY - JOUR AU - Shim, H. J. AU - Cho, S. H. AU - Hwang, J. E. PY - 2010 DA - 2010// TI - Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer JO - Am J Clin Oncol VL - 33 UR - https://doi.org/10.1097/COC.0b013e3181bead92 DO - 10.1097/COC.0b013e3181bead92 ID - Shim2010 ER - TY - JOUR AU - Font, A. AU - Arellano, A. AU - Fernandez-Llamazares, J. PY - 2007 DA - 2007// TI - Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer JO - Clin Transl Oncol VL - 9 UR - https://doi.org/10.1007/s12094-007-0032-5 DO - 10.1007/s12094-007-0032-5 ID - Font2007 ER - TY - JOUR AU - Shim, H. J. AU - Kim, D. E. AU - Hwang, J. E. PY - 2012 DA - 2012// TI - A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer JO - Cancer Chemother Pharmacol VL - 70 UR - https://doi.org/10.1007/s00280-012-1962-3 DO - 10.1007/s00280-012-1962-3 ID - Shim2012 ER - TY - JOUR AU - Higuchi, K. AU - Komori, S. AU - Tanabe, S. PY - 2014 DA - 2014// TI - Definitive Chemoradiation therapy with Docetaxel, Cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal Cancer: a phase 2 trial (KDOG 0501-P2) JO - Int J Radiat Oncol Biol Phys VL - 89 UR - https://doi.org/10.1016/j.ijrobp.2014.03.030 DO - 10.1016/j.ijrobp.2014.03.030 ID - Higuchi2014 ER - TY - JOUR AU - Miyata, H. AU - Yamasaki, M. AU - Kurokawa, Y. PY - 2011 DA - 2011// TI - Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1747-7 DO - 10.1245/s10434-011-1747-7 ID - Miyata2011 ER - TY - JOUR AU - Blom, R. L. AU - Lagarde, S. M. AU - Oudenaarde, K. PY - 2013 DA - 2013// TI - Survival after recurrent esophageal carcinoma has not improved over the past 18 years JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-013-2936-3 DO - 10.1245/s10434-013-2936-3 ID - Blom2013 ER - TY - JOUR AU - Nakamura, T. AU - Ota, M. AU - Narumiya, K. PY - 2008 DA - 2008// TI - Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection JO - Ann Surg Oncol VL - 15 UR - https://doi.org/10.1245/s10434-008-0016-x DO - 10.1245/s10434-008-0016-x ID - Nakamura2008 ER - TY - JOUR AU - Makino, T. AU - Yamasaki, M. AU - Miyata, H. PY - 2016 DA - 2016// TI - Solitary lymph node recurrence of esophageal squamous cell carcinoma: surgical failure or systemic disease? JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-015-5086-y DO - 10.1245/s10434-015-5086-y ID - Makino2016 ER - TY - JOUR AU - Shimada, H. AU - Kitabayashi, H. AU - Nabeya, Y. PY - 2003 DA - 2003// TI - Treatment response and prognosis of patients after recurrence of esophageal cancer JO - Surgery VL - 133 UR - https://doi.org/10.1067/msy.2003.31 DO - 10.1067/msy.2003.31 ID - Shimada2003 ER - TY - JOUR AU - Xia, Y. AU - Li, Y. H. AU - Chen, Y. PY - 2018 DA - 2018// TI - A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma JO - Int J Clin Oncol VL - 23 UR - https://doi.org/10.1007/s10147-018-1240-4 DO - 10.1007/s10147-018-1240-4 ID - Xia2018 ER - TY - JOUR AU - Day, F. L. AU - Leong, T. AU - Ngan, S. PY - 2011 DA - 2011// TI - Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer JO - Br J Cancer VL - 104 UR - https://doi.org/10.1038/sj.bjc.6606051 DO - 10.1038/sj.bjc.6606051 ID - Day2011 ER - TY - JOUR AU - Zhu, Y. AU - Zhang, W. AU - Li, Q. PY - 2017 DA - 2017// TI - A phase II randomized controlled trial: definitive concurrent Chemoradiotherapy with Docetaxel plus Cisplatin versus 5-fluorouracil plus Cisplatin in patients with Oesophageal squamous cell carcinoma JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.20053 DO - 10.7150/jca.20053 ID - Zhu2017 ER -